Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 6.18%4.55B | 9.95%17.51B | 8.85%4.64B | 5.56%4.3B | 7.32%4.29B | 19.11%4.29B | 23.03%15.92B | 21.83%4.26B | 19.74%4.07B | 28.08%3.99B |
Cost of revenue | 11.61%2.06B | 6.80%7.74B | 7.11%2.1B | 5.00%1.92B | 2.42%1.87B | 13.36%1.85B | 16.71%7.24B | 14.53%1.96B | 15.87%1.83B | 22.52%1.82B |
Gross profit | 2.06%2.49B | 12.57%9.77B | 10.33%2.54B | 6.02%2.38B | 11.45%2.42B | 23.89%2.44B | 28.85%8.68B | 28.80%2.3B | 23.10%2.24B | 33.17%2.17B |
Operating expense | 9.10%1.41B | 7.30%5.51B | 10.71%1.54B | 6.87%1.35B | 6.67%1.32B | 4.52%1.29B | 10.71%5.13B | 13.26%1.4B | 12.18%1.26B | 11.01%1.24B |
Operating profit | -5.92%1.07B | 20.19%4.26B | 9.74%996.83M | 4.92%1.03B | 17.80%1.1B | 56.80%1.14B | 68.90%3.55B | 63.21%908.33M | 40.74%979.98M | 81.35%930.83M |
Net non-operating interest income (expenses) | 3.93%-220K | 22.45%-539K | -59K | 21.09%-202K | 66.44%-49K | 21.84%-229K | 41.55%-695K | 0 | 52.06%-256K | 4.58%-146K |
Non-operating interest expense | -3.93%220K | -22.45%539K | --59K | -21.09%202K | -66.44%49K | -21.84%229K | -41.55%695K | --0 | -52.06%256K | -4.58%146K |
Net investment income | -16.07%-65K | -56K | ||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | -5,533.85%-230.2M | -5,546.28%-230.2M | 0 | 0 | 0 | -107.20%-4.09M | -21.16%-4.08M | 0 | 91.35%-9K |
Less:Other special charges | ---- | 5,533.85%230.2M | ---- | ---- | ---- | ---- | 107.20%4.09M | 21.16%4.08M | --0 | ---- |
Other non-operating income (expenses) | 16.80%4.92M | -10.03%22M | -1.17%3.79M | 13.63%7.55M | -36.76%6.45M | 11.50%4.21M | 11.89%24.45M | 5.65%3.84M | 24.57%6.65M | 49.56%10.19M |
Income before tax | -5.84%1.08B | 13.67%4.06B | -15.17%770.3M | 4.99%1.04B | 17.23%1.1B | 56.59%1.15B | 68.34%3.57B | 63.09%908.04M | 40.69%986.37M | 80.99%940.87M |
Income tax | -16.56%333.55M | 6.61%1.17B | -59.05%67.38M | -6.10%340.86M | 17.79%359.47M | 52.40%399.74M | 47.74%1.1B | -9.07%164.54M | 38.06%363.01M | 80.71%305.18M |
Net income | -0.10%745.69M | 16.80%2.89B | -5.46%702.92M | 11.45%694.71M | 16.96%743.48M | 58.94%746.46M | 79.42%2.47B | 97.83%743.5M | 42.27%623.36M | 81.13%635.69M |
Net income continuous operations | -0.10%745.69M | 16.80%2.89B | -5.46%702.92M | 11.45%694.71M | 16.96%743.48M | 58.94%746.46M | 79.42%2.47B | 97.83%743.5M | 42.27%623.36M | 81.13%635.69M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -0.10%745.69M | 16.80%2.89B | -5.46%702.92M | 11.45%694.71M | 16.96%743.48M | 58.94%746.46M | 79.42%2.47B | 97.83%743.5M | 42.27%623.36M | 81.13%635.69M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -0.10%745.69M | 16.80%2.89B | -5.46%702.92M | 11.45%694.71M | 16.96%743.48M | 58.94%746.46M | 79.42%2.47B | 97.83%743.5M | 42.27%623.36M | 81.13%635.69M |
Gross dividend payment | ||||||||||
Basic earnings per share | -0.10%29.79 | 16.81%115.36 | -5.45%28.08 | 11.44%27.76 | 16.98%29.7 | 58.96%29.82 | 79.43%98.76 | 97.87%29.7 | 42.34%24.91 | 81.10%25.39 |
Diluted earnings per share | -0.10%29.79 | 16.81%115.36 | -5.45%28.08 | 11.46%27.7536 | 16.98%29.7 | 58.96%29.82 | 79.43%98.76 | 97.87%29.7 | 42.29%24.9006 | 81.12%25.39 |
Dividend per share | 0 | 32.26%41 | 25.00%25 | 0 | 45.45%16 | 0 | 72.22%31 | 100.00%20 | 0 | 37.50%11 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |